Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-20-002027

SVP, Business Development sold 4,020 shares at $15.93 ($64,021)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Birznieks Gunther SVP, Business Development 2020-01-02 Sale −4,020 $15.93 $64,021 147,231 D: show line 1 in the form
Open-market sales · 4,020 sh · avg $15.93 · $64,021
Loading xslF345X03/doc4.xml…